Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
RenovoRx, Inc.Listing on record | AwardD (derivative) | — | SEC | |
RenovoRx, Inc.Listing on record | AwardD (derivative) | — | SEC | |
RenovoRx, Inc.Listing on record | AwardD (derivative) | — | SEC | |
RenovoRx, Inc.Listing on record | AwardD (derivative) | — | SEC | |
RenovoRx, Inc.Listing on record | AwardD (derivative) | — | SEC | |
RenovoRx, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Oncotelic Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
dELiAs, Inc.Listing unverified | Other | $441.6 | SEC | |
dELiAs, Inc.Listing unverified | Other | $30 | SEC | |
dELiAs, Inc.Listing unverified | Other | $162.5 | SEC | |
dELiAs, Inc.Listing unverified | Award | — | SEC | |
dELiAs, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
dELiAs, Inc.Listing unverified | Award | — | SEC | |
dELiAs, Inc.Listing unverified | Award | — | SEC | |
dELiAs, Inc.Listing unverified | Other | — | SEC |